Trial Profile
Paclitaxel polymeric micelle regimen [GENEXOL-PM] in advanced and metastatic non-small-cell-lung-cancer (NSCLC) patients.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Sep 2015
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 01 Sep 2015 New trial record